A Phase I/II Study of Sequential Chemoradiation Followed by Autologous Stem Cell Transplant in Patients with Untreated Advanced Mantle Cell Lymphoma
[Protocol 11-095] |
Zelenetz, Andrew |
|
A Phase III Study of Rituximab plus GS-1101 (CAL-101) or Placebo for Previously Treated Chronic Lymphocytic Leukemia
[Protocol 12-160] |
Zelenetz, Andrew |
- Leukemia
- Chronic Lymphocytic Leukemia
|
A Phase III Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients with Metastatic Cancer
[Protocol 10-154] |
Zelefsky, Michael |
|
A Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056] |
Zelefsky, Michael |
|
A Phase III Study of ProstAtakTM as an Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer
[Protocol 11-172] |
Zelefsky, Michael |
|
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035] |
Zelefsky, Michael |
|
A Phase III Trial of Short-Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed-Only Radiotherapy in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
[Protocol 09-102] |
Zelefsky, Michael |
- Prostate Cancer
- Localized Disease
- Rising PSA After Primary Therapy
|
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112] |
Zaider, Talia |
- Prostate Cancer
- Localized Disease
- Quality of Life
|
A Phase IB Dose-Escalation and Safety Study of LDE225 plus Gemcitabine in Patients with Locally Advanced or Metastatic Pancreatic Cancer
[Protocol 12-036] |
Yu, Kenneth |
- Hepatobiliary
- Upper Gastrointestinal
|
A Phase I Study of an mRNA-Modified Dendritic Cell Vaccine in Patients with Melanoma
[Protocol 10-229] |
Young, James |
|
A Phase I Study of CUDC-907 in Patients with Relapsed or Refractory Lymphoma or Multiple Myeloma
[Protocol 13-045] |
Younes, Anas |
|
A Pilot Study of Image-Guided Navigation for High-Dose Rate Brachytherapy to Manage Discomfort in Patients with Previously Treated Spine Tumors
[Protocol 12-260] |
Yamada, Yoshiya |
|
A Pilot Study of Vemurafenib and Panitumumab in Patients with BRAF V600E-Mutated Metastatic Colorectal Cancer
[Protocol 12-221] |
Yaeger, Rona |
|
A Phase II Study Evaluating the Addition of Trastuzumab to Standard Therapy for HER2-Positive Esophageal Cancers
[Protocol 12-094] |
Wu, Abraham |
|
Heart-Sparing Whole Lung IMRT in Children and Young Adults with Lung Metastases: A Feasibility Study
[Protocol 11-100] |
Wolden, Suzanne |
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Rhabdomyosarcoma
|
A Phase Ib Study of MDX-1106 (BMS-936558) in Combination with Ipilimumab (BMS-734016) in Patients with Unresectable Stage III or Stage IV Malignant Melanoma
[Protocol 09-155] |
Wolchok, Jedd |
|
A Study of the Biologic Effects of BMS-936558 in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-231] |
Wolchok, Jedd |
|
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253] |
Wolchok, Jedd |
|
A Phase II Study of Cixutumumab plus Temsirolimus in Children with Recurrent or Refractory Sarcoma
[Protocol 12-188] |
Wexler, Leonard |
- Primary Bone
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase II Trial of Vinorelbine and Cyclophosphamide with Bevacizumab or Temsirolimus in Patients with Recurrent/Refractory Rhabdomyosarcoma
[Protocol 11-026] |
Wexler, Leonard |
- Sarcomas
- Rhabdomyosarcoma
- Soft Tissue Sarcoma
|
